Human Heart-Type Fatty Acid-Binding Protein as an Early Diagnostic Marker of Doxorubicin Cardiac Toxicity
Abstract
Share and Cite
ElGhandour, A.H.; El Sorady, M.; Azab, S.; ElRahman, M. Human Heart-Type Fatty Acid-Binding Protein as an Early Diagnostic Marker of Doxorubicin Cardiac Toxicity. Hematol. Rev. 2009, 1, e6. https://doi.org/10.4081/hr.2009.e6
ElGhandour AH, El Sorady M, Azab S, ElRahman M. Human Heart-Type Fatty Acid-Binding Protein as an Early Diagnostic Marker of Doxorubicin Cardiac Toxicity. Hematology Reviews. 2009; 1(1):e6. https://doi.org/10.4081/hr.2009.e6
Chicago/Turabian StyleElGhandour, Ashraf H., Manal El Sorady, Sahar Azab, and Mohammed ElRahman. 2009. "Human Heart-Type Fatty Acid-Binding Protein as an Early Diagnostic Marker of Doxorubicin Cardiac Toxicity" Hematology Reviews 1, no. 1: e6. https://doi.org/10.4081/hr.2009.e6
APA StyleElGhandour, A. H., El Sorady, M., Azab, S., & ElRahman, M. (2009). Human Heart-Type Fatty Acid-Binding Protein as an Early Diagnostic Marker of Doxorubicin Cardiac Toxicity. Hematology Reviews, 1(1), e6. https://doi.org/10.4081/hr.2009.e6